New hypertension guidelines change the approach for patients aged 65-79: not everyone needs pills right away

An analysis was published in the Annals of Internal Medicine on March 17, 2026, showing how new US hypertension guidelines change the indications for initiating drug therapy in older adults. The study focuses on adults aged 65-79 with untreated stage 1 hypertension and addresses a practical question: how many people, under the new guidelines, no longer require immediate antihypertensive medication.

The essence of this change is that the 2025 guidelines from the American Heart Association and the American College of Cardiology have shifted from a nearly automatic age-based approach to a risk-based one. Now, for stage 1 hypertension, the decision to initiate medication is based not only on blood pressure and age, but also on the 10-year cardiovascular risk score based on the PREVENT score, as well as the presence of diabetes, chronic kidney disease, previous stroke, or other cardiovascular disease.

According to the official summary of the publication, approximately 11.4% of adults aged 65-79 with untreated stage 1 hypertension are no longer eligible for immediate medication under the new criteria. In other words, approximately 1 in 9 of these patients can now begin treatment not with pills, but with a more careful risk assessment and non-pharmacological measures.

This is significant news for clinical practice because it changes not the target blood pressure level per se, but the very moment of treatment initiation. The document doesn't say that hypertension in the elderly has become less important. It does say something else: some relatively healthy people aged 65-68 with moderately elevated blood pressure and a low estimated risk do not necessarily need to start medication at the same time stage 1 hypertension is first diagnosed.

Below is the table showing the key figures of this news. [1]

Parameter	What the analysis showed
Magazine	Annals of Internal Medicine
Online publication date	March 17, 2026
Type of work	Cross-sectional analysis
Age	65-79 years old
What was compared?	The old age-based approach and new risk-based rules
The main conclusion	11.4% of elderly people with untreated stage 1 hypertension no longer require immediate medication initiation
Practical meaning	The decision now depends more often on overall cardiovascular risk, rather than just age.

How the study was conducted

The authors used data from the US National Health and Nutrition Examination Survey for the period from January 2013 to March 2020. The analysis included adults aged 65–79 years, and then separately identified those with stage 1 hypertension who were not yet receiving antihypertensive therapy.

The study was not a randomized clinical trial. It was a cross-sectional analysis, meaning the researchers didn't observe the impact of a future change in treatment strategy, but rather examined how the same people would be classified under the old and new guidelines. This design is well suited for assessing the magnitude of reclassification, but it cannot, by itself, prove whether forgoing immediate treatment will improve or worsen long-term outcomes.

The new decision-making framework is based on the PREVENT score. The 2025 guidelines recommend antihypertensive therapy for stage 1 hypertension immediately if the 10-year cardiovascular risk is 7.5% or higher, or if there is pre-existing diabetes, chronic kidney disease, or established cardiovascular disease. For patients with lower risk, lifestyle changes are the first line of defense.

This is also important because the new guidelines do not eliminate blood pressure assessment per se. Stage 1 hypertension is still defined as a systolic pressure of 130-139 mmHg or a diastolic pressure of 80-89 mmHg. What has changed is not the diagnosis, but the logic behind initiating drug treatment.

The table below shows the analysis device.[2]

Component	Description
Data source	National Health and Nutrition Examination Survey
Period	2013-2020
Age of participants	65-79 years old
Focus	Untreated hypertension stage 1
The old approach	Age 65 years and older actually led to earlier treatment initiation on its own.
A new approach	The decision depends on the PREVENT risk and comorbidities
Type of analysis	Cross-sectional, comparative

What exactly did the researchers find?

According to the official summary of the article, among 2,099 adults aged 65-79 in the sample, 169 had untreated stage 1 hypertension. Under the previous guidelines, all 169 were eligible for drug therapy, but under the new guidelines, only 156, or 88.6%, were eligible for immediate medication. The remaining 11.4% were reclassified as having no immediate need to initiate medication.

The most interesting profile was that of people who "dropped out" of the old automatic assignment scheme. According to the study summary, they were all women, non-smokers, aged 65-68, and had no diabetes, chronic kidney disease, or established cardiovascular disease. This is a very characteristic profile: not simply "elderly," but relatively young patients within an elderly group, and metabolically more healthy.

In this reclassified group, the calculated risk according to PREVENT was 4.8%–7.4%, remaining below the new threshold of 7.5%. Additional indicators also looked comparatively favorable: normal or near-normal kidney function, non-smoking, and a more stable overall cardiometabolic profile. This helps us understand that the new guidelines do not "cancel treatment for the elderly," but rather attempt to more accurately separate truly high-risk patients from those who can be given a chance to initially pursue a non-drug-based approach.

However, as the paper's retellings note, the majority of already treated elderly patients would still remain in the treatment-justified category under the new system. This means that the document primarily changes the approach to initiating treatment for a limited subgroup, rather than upending the entire practice of managing hypertension in the elderly.

Below is a short table of the main results. [3]

Result	Meaning
People aged 65-79 in the sample	2099
With untreated stage 1 hypertension	169
Would have been eligible for treatment under the old rules	100%
Had indications for immediate treatment according to the new rules	88.6%
Lost automatic readings	11.4%
Typical profile of a reclassified patient	Woman 65-68 years old, non-smoker, no diabetes, no chronic kidney disease, no cardiovascular disease

What does this change for doctors and patients?

The most practical conclusion from this publication is that age 65 alone is no longer sufficient to immediately prescribe antihypertensive therapy for stage 1 hypertension. Now, physicians must first calculate the PREVENT risk and assess the presence of diabetes, chronic kidney disease, or previous cardiovascular events.

For the patient, this means a more personalized conversation. If a person aged 65-68 has blood pressure in the stage 1 hypertension range, but does not smoke, has no diabetes, kidney disease, or significant cardiovascular history, the doctor may initially recommend active salt reduction, weight loss if overweight, physical activity, sleep monitoring, and repeated blood pressure monitoring, rather than immediately starting medications.

But there's an important caveat here. The new guidelines don't simply recommend "doing nothing" for patients with a risk below 7.5%. Official materials from the American Heart Association emphasize that if, after 3-6 months of lifestyle changes, average blood pressure remains 130 over 80 millimeters of mercury or higher, drug therapy is still recommended. This suggests a delayed and more informed initiation, rather than a complete refusal of treatment.

Another important point is that the overall blood pressure target in the guidelines remains strict. The document still considers a target level of less than 130/80 mmHg as the primary goal for adults; the path to achieving this goal simply begins differently for different groups. Some start with medication, while others begin with intensive lifestyle changes.

The table below shows what this logic looks like in practice. [4]

Clinical situation	What do the new rules recommend?
Stage 2 hypertension	Start drug treatment
Stage 1 hypertension + diabetes	Start drug treatment
Stage 1 hypertension + chronic kidney disease	Start drug treatment
Stage 1 hypertension + cardiovascular disease	Start drug treatment
Stage 1 hypertension + PREVENT risk ≥7.5%	Start drug treatment
Stage 1 hypertension + PREVENT risk <7.5%	First 3-6 months of lifestyle changes, then re-evaluation

Limitations of the study and main conclusion

This study has important limitations, and they should not be overlooked. It is not a study that compared outcomes in people who started treatment immediately with those who did not. Therefore, the publication does not prove that the reclassified group is definitely safer to wait with medications. It only shows how the new recommendation recategorizes patients.

Furthermore, a cross-sectional design is poorly suited for accurately assessing already treated patients, as it is difficult to restore baseline values before therapy. Therefore, conclusions about those already taking antihypertensive medications are inevitably less definitive than those about people with untreated stage 1 hypertension.

There's another limitation: the analysis focused on adults aged 65-79, not people aged 80 and older. Therefore, these results cannot be generalized to the entire very elderly population without reservation. However, for the 65-79 age group, the study provides a fairly clear and clinically useful signal: some patients at the lower end of this age group should no longer automatically receive medications simply because they have turned 65. [5]

The main conclusion of the news can be summarized as follows: the new hypertension guidelines make treatment more targeted in the elderly. For most adults aged 65-79 with stage 1 hypertension, the treatment logic remains largely unchanged, but for approximately 1 in 9 untreated patients, the decision to initiate medication should now be based on PREVENT risk and comorbidities, not just age. This is a step toward more personalized prevention of cardiovascular complications.

The final table - in 1 glance. [6]

The main question	Short answer
Do all people over 65 with stage 1 hypertension need to take pills right away?	No
What was the main criterion?	10-year PREVENT risk and presence of high-risk diseases
Who is most likely to fall outside the indications for immediate treatment?	Women aged 65-68 years without smoking and without major comorbidities
Does this mean that treatment has become gentler for everyone?	No, only for a small, low-risk subgroup
Has targeted blood pressure monitoring been abolished?	No, the target of less than 130 to 80 remains.
What should a patient do in practice?	Confirm pressure, calculate risk, discuss lifestyle and timing of re-evaluation

News source: Sridhar Mangalesh, Raiza Rossi, Armin Nouri, Abdulla A. Damluji, Michael G. Nanna. Risk-Guided Antihypertensive Treatment Eligibility in Older Adults Under Updated Hypertension Guidelines. Annals of Internal Medicine. Published online March 17, 2026. DOI: 10.7326/ANNALS-25-04519.